Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Capital investment

- PMLiVE

The UK reasserts that the AZ vaccine is ‘effective across all age groups’

Germany's draft guidance does not recommend the vaccine for people over 65

- PMLiVE

UK contributes £210m towards COVID-19 vaccine efforts

Prime Minister Boris Johnson also tests positive for coronavirus

- PMLiVE

UK ramps up measures to combat coronavirus spread

New advice encourages ‘social-distancing’ as cases expected to soar

- PMLiVE

UK officially moves into ‘delay’ phase of coronavirus plan

New measures includes broader self-isolation advice

- PMLiVE

UK government considers move into ‘delay’ phase of coronavirus response plan

Proposed emergency measures could include 'social distancing'

- PMLiVE

Doctors worried NHS is unprepared for coronavirus as government unveils action plan

Concerns raised as government reveals key planning document

- PMLiVE

NHS reliance on ‘short-term measures’ has made it financially unstable, auditors report

Quick fixes are draining funding for long-term investment

- PMLiVE

Boris Johnson to unveil ‘talent visa’ for high-flying scientists

Global Talent visa due to come into effect on 20 February

- PMLiVE

Brexit nears as Conservatives sweep to victory in election

British pharma association 'looks forward to working with the new Government'

- PMLiVE

Boris Johnson pledges fast-track visas for key NHS workers

New system will accelerate cut-price visas for doctors and nurses

- PMLiVE

Another day, another Brexit delay – so what happens now?

Health Secretary Matt Hancock maintains UK will retain regulatory collaboration with EMA

- PMLiVE

Johnson pledges £200m cash injection into UK’s life sciences sector

UK-based entrepreneurs “share his ambition”, says industry leader

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links